quadraScope Venture Fund
Venture capitalBoston · 2 people tracked
Investment thesis
quadraScope focuses on the emerging rejuvenation and longevity biotech market, investing in companies addressing the biological hallmarks of aging—including genomic instability, telomere attrition, epigenetic alterations, cellular senescence, and mitochondrial dysfunction. The firm invests across the drug development lifecycle, from preclinical research to clinical development stages, backing diverse therapeutic modalities including nanomedicines, cellular reprogramming, regenerative medicine, and lipid-based metabolic treatments that target the root biological causes of aging-related diseases.
Source: firm website, verified Aug 6, 2026.
Team · 2 people
from public directories
Frequently asked questions
- What sectors does quadraScope Venture Fund focus on?
- quadraScope Venture Fund focuses on Biotech, Healthtech, Longevity, Medical Devices.
- Where is quadraScope Venture Fund located?
- quadraScope Venture Fund is headquartered in Boston, US.
Images
Co-investors · 2
Cyberstarts is a venture firm focused on cybersecurity startups, backing founders who have overcome significant challenges and using a systematic process to identify urgent problems in the sector.
Esplanade Ventures is a Canadian venture capital firm focused on early-stage digital health technology companies transforming care in the U.S. and Canada.
Firms observed investing alongside quadraScope Venture Fund, from public investor directories.
Similar investors
Future Positive Capital is an investment firm backing entrepreneurs building companies that address major global challenges and shape more sustainable, preferable futures.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
EQT Life Sciences, formerly LSP (Life Sciences Partners), is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech.
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
Averin Capital is an investment firm focused on the intersection of technology and health, backing teams building companies in areas such as early disease detection, treatment delivery, personalized care, and medical breakthroughs.